Please login to the form below
Vertex Pharma
This page shows the latest Vertex Pharma news and features for those working in and with pharma, biotech and healthcare.
Is Orkambi deal close? Vertex meets again today with NHS England
This was followed by a meeting between Vertex CEO Jeff Leiden and UK health secretary Matt Hancock, who described the talks as ‘constructive’. ... This in turn led to the pharma company restarting talks with NICE and NHS England, with a second
Latest news
-
Unruffled by ‘outlier’ claims, Vertex CEO upbeat on Orkambi breakthrough
Vertex CEO Jeff Leiden. The deadlock between pharma company Vertex and NHS England over cystic fibrosis drug Orkambi was played out today in a parliamentary hearing in London, with the ... Both sides have thrown accusations via public statements and the
-
Vertex chief Jeffrey Leiden to weigh in on Orkambi inquiry
After a rejection, pharma companies would then normally pursue negotiations with NICE to come to an agreement that’s beneficial to all parties involved. ... The UK could be a big market for Vertex, which has been facing mounting pressure from patient
-
UK patient activist group takes aim at Orkambi patent
But Vertex rejected that offer, and have also withdrawn Symkevi from the appraisal process of cost effectiveness watchdog NICE. ... Nevertheless, the campaign will place more pressure on Vertex to agree to the UK pricing demands.
-
Vertex an “extreme outlier” in pricing and behaviour, says NHS England
Vertex says it offered an unprecedented confidential discount to NHS England, but this was rejected last summer. ... government’s lack of flexibility on prices jeopardised pharma investment in the country ahead of Brexit.
-
Hardy returns to Genentech as CEO
Vertex dismisses COO after misconduct. Meanwhile, Vertex has a much less happy boardroom reshuffle to announce. ... He adds: “Vertex has a strong management team in place, as well as a deep bench.
More from news
Approximately 6 fully matching, plus 37 partially matching documents found.
Latest Intelligence
-
2019: CRISPR and therapeutic gene editing comes of age
The green light came after a delay of around a year caused by manufacturing issues, which allowed another candidate from CRISPR Therapeutics and Vertex Pharma - CTX001 for the rare blood disease
-
The challenges of making genomics a reality for patients today, not tomorrow
and higher risk science. The report singles out Vertex among a handful of successful biotech companies with highly innovative products. ... Dr Gillian Burgess is site head of UK Research and Vice President at Vertex.
-
Deal Watch table for November 2014
Table listing all the major pharma mergers, acquisitions and collaborations in the past month. ... For an indepth analysis of these deals, read'Pharma deals during November 2014'.
-
Pharma deals during November 2014
Reckitt Benckiser(RB) is spinning out its pharma business unit, under the name Indivior. ... On a mission. Continuing its trend of helping companies monetise their future income streams, Royalty Pharma is buying royalties in Vertex Pharmaceutical's
More from intelligence
Approximately 1 fully matching, plus 3 partially matching documents found.
Latest appointments
-
Vertex poaches new finance chief from Ironwood Pharmaceuticals
Boston-based biotech company appoints Tom Graney. Vertex lured Tom Graney away from Ironwood Pharmaceuticals, appointing him as its new senior vice president and chief financial officer. ... Tom has the ideal blend of financial acumen, leadership skills,
-
BMS appoints three independent directors
Meanwhile, Matthew Emmens and Theodore Samuels also join the pharma firm's board of directors. ... Since beginning his pharmaceutical career 40 years ago, Emmens has served as president, chief executive officer and chairman of Vertex Pharma, chief
More from appointments
Approximately 0 fully matching, plus 2 partially matching documents found.
Latest from PMHub
-
Cogora
Nutricia. Orion Pharma. Orphan Europe. Pfizer. Portola. Prostate Cancer UK. Primary Care Respiratory Society. ... Reckitt Benckiser. Stallergenes. Sun Pharma. Takeda. ThermoFisher Scientific. Vertex.
-
Random42 Scientific Communication
Collegium Pharmaceutical. CSL Behring. Dainippon Sumitomo Pharma. Daiichi-Sankyo. DePuy Synthes. DBV Technologies . ... Unilever. Vasopharm. Vertex. Vetoquinol. Vifor Pharma. VR1 Inc. Wyss Center. Xenetic Biosciences.
More from PMHub
Approximately 0 fully matching, plus 2 partially matching documents found.
Featured jobs
- Home-based Senior Medical Writer – Med Ed
-
Salary TBC
-
Account Director, Medical Education
-
Salary TBC
- Science Writer, Healthcare Advertising Agency
-
£40, 000 - 45, 000 DOE benefits,
-
Senior Medical Writer
-
Salary TBC
- Associate Director – Social Healthcare – London
-
HIGHLEY COMPETATIVE SALARY, BONUS &BENEFITS
-
Creative/ Medical Writer
-
Circa £35, 000 With Benefits
- Senior Account Manager, Medical Communications, London
-
Excellent package
- Senior Account Executive – Account Manager – Healthcare Advertis...
-
£32000 - £43000 Bonus Benfits
-
Health Consultant - Brand Comms
-
Competitive Salary
- Account Manager, Medical Communications and Marketing
-
£30, 000 – £40, 000 benefits and bonus
- Scientific Director – Medical Communications - New York or Remot...
-
$100000 - $150000
- EU Head of Business Development and Client Service
-
Exceptional packge and bonus
- Scientific Director – Medical Communications
-
Salary TBC
- Home based, Senior Medical Writer, Medical Communications
-
Excellent package
Subscribe to our email news alerts
- Setback for Vertex’s cystic fibrosis challenger Proteostasis
- Celgene hopes for second time lucky for ozanimod FDA filing
- Bluebird plays down report of EU gene therapy approval
- Aimmune preps EU filing for peanut allergy immunotherapy
- DDB Remedy, Cuttsy + Cuttsy and Cello win agency workplace awards
- Janssen looks to expand Darzalex in Europe
PMHub
Virgo Health
Virgo Health is an award-winning global healthcare communications and medical education agency comprising specialists with some of the best skills,...
Latest intelligence
- 50 questions for delivering an exceptional healthcare brand experience
- Our 50-question brand planning checklist for healthcare ensures you deliver an exceptional experience, based on what your stakeholders want and need...
- The brand strategy revolution
- Introducing a new tool for developing a stakeholder-centric brand, based on the experience your patients and their HCPs want and need....
- How Medisafe is using AI to improve patient adherence
- Dina Patel speaks to Omri Shor, Co-Founder and CEO of Medisafe, to find out how his medication management app is tackling the problem of poor adherence....
Quick links
Infographics
